Negative regulation of urokinase-type plasminogen activator production through FGF-2-mediated activation of phosphoinositide 3-kinase

Oncogene

Volumn 21, Issue 46, 2002, Pages 7027-7033

  Mochizuki, Yasushi ^a   Tsuda, Satoshi ^a   Kanetake, Hiroshi ^a   Kanda, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Endothelial cells; FGF 2; L6 myoblasts; PI3 kinase; Ras; UPA

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; FIBROBLAST GROWTH FACTOR 2; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PLASMINOGEN ACTIVATOR; PROTEIN P110; PROTEIN P85; PROTEIN SUBUNIT; UNCLASSIFIED DRUG; UROKINASE; WORTMANNIN;

ANIMAL CELL; ARTICLE; DRUG ACTIVITY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME SYNTHESIS; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CATALYTIC DOMAIN; ENZYME ACTIVATION; FIBROBLAST GROWTH FACTOR 2; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; RAS PROTEINS; URINARY PLASMINOGEN ACTIVATOR;

ANIMALIA; MURINAE; SUIDAE;

EID: 0037057345     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205736     Document Type: Article

References (43)

1. Aguirre-Ghiso JA, Alonso DF, Farias EF, Gomez DE and Joffe EBK. (1999a). Eur. J. Biochem., 263, 295-304.
2. Aguirre-Ghiso JA, Flankel P, Farias EF, Lu Z, Olsen JA, Feig LA, Joffe EBK and Foster DA. (1999b). Oncogene, 18, 4718-4725.
3. Bajou K, Noël A, Gerard RD, Masson V, Brunner N, Holst- Hansen C, Skobe M, Fusenig NE, Carmeliet P, Collen D and Foidart JM. (1998). Nature Med., 4, 923-928.
4. Bajou K, Masson V, Gerard RD, Schmitt PM, Albert V, Praus M, Lund LR, Frandsen TL, Brunner N, Dano K, Fusenig NE, Weidle U, Carmeliet G, Loskutoff D, Collen D, Carmeliet P, Foidart JM and Noël A. (2001). J. Cell Biol., 152, 777-784.
5. Blasi F. (1993). BioEssays, 15, 105-111.
6. Boilly B, Vercoutter-Edouart AS, Hondermarck H, Nurcombe V and Le Bourhis X. (2000). Cytokine Growth Factor Rev., 11, 295-302.
7. Chan TO, Rittenhouse SE and Tsichlis PN. (1999). Annu. Rev. Biochem., 68, 965-1014.
8. Duronio V, Scheid MP and Ettinger S. (1998). Cell Signal., 10, 233-239.
9. Fruman DA, Meyers RE and Cantley LC. (1998). Annu. Rev. Biochem., 67, 481-507.
10. Giuliani R, Bastaki M, Coltrini D and Presta M. (1999). J. Cell Sci., 112, 2597-2606.
11. Gum R, Juarez J, Allegayer H, Mazar A, Wang Y and Boyd D. (1998). Oncogene, 17, 213-225.
12. Holt KH, Olson L, Moye-Rowley WS and Pessin JE. (1994). Mol. Cell. Biol., 14, 42-49.
13. Jiang B-H, Zheng JZ, Aoki M and Vogt PK. (2000). Proc. Natl. Acad. Sci. USA, 97, 1749-1753.
14. Kanda S, Hodgkin MN, Woodfield RJ, Wakelam MJO, Thomas G and Claesson-Welsh L. (1997). J. Biol. Chem., 272, 23347-23353.
15. Kanda S, Landgren E, Ljungström M and Claesson-Welsh L. (1996). Cell Growth Differ., 7, 383-395.
16. Klint P and Claesson-Welsh L. (1999). Frontiers Biosci., 4, d165-d177.
17. Klint P, Kanda S and Claesson-Welsh L. (1995). J. Biol. Chem., 270, 23337-23344.
18. Klippel A, Escobedo JA, Fantl WJ and Williams LT. (1992). Mol. Cell. Biol., 12, 1451-1459.
19. Klippel A, Reinhard C, Fantl WJ and Williams LT. (1996). Mol. Cell. Biol., 16, 4117-4127.
20. Kotani K, Ogawa W, Hino Y, Kitamura T, Ueno H, Sano W, Sutherland C, Granner DK and Kasuga M. (1999). J. Biol. Chem., 274, 21305-21312.
21. Kotani K, Yonezawa K, Hara K, Ueda H, Kitamura Y, Sakaue H, Ando A, Chavanieu A, Calas B, Grigorescu F, Nishiyama M, Waterfield MD and Kasuga M. (1994). EMBO J., 13, 2313-2321.
22. Koziczak M, Krek W and Nagamine Y. (2000). Mol. Cell. Biol., 20, 2014-2022.
23. Mohammadi M, Dikic I, Sorokin A, Burgess WH, Jaye M and Schlessinger J. (1996). Mol. Cell. Biol., 16, 977-989.
24. Ogawa W, Matozaki T and Kasuga M. (1998). Mol. Cell. Biochem., 182, 13-22.
25. Ong SH, Hadari YR, Gotoh N, Guy GR, Schlessinger J and Lax I. (2001). Proc. Natl. Acad. Sci. USA, 98, 6074-6079.
26. Pepper MS, Montesano R, Mandriota SJ, Orci L and Vassalli JD. (1996). Enzyme Protein., 49, 138-162.
27. Raffioni S and Bradshow RA. (1992). Proc. Natl. Acad. Sci. USA, 89, 9121-9125.
28. Rodriguez-Viciana P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry MJ, Waterfield MD and Downward J. (1994a). Nature, 370, 527-532.
29. Rodriguez-Viciana P, Warne PH, Vanhaesebroeck B, Water-Field MD and Downward J. (1994b). EMBO J., 15, 2442-2451.
30. Roghani M, Mohammadi M, Schlessinger J and Moscatelli D. (1996). J. Biol. Chem., 271, 31154-31159.
31. Rommel C, Clarke BA, Zimmermann S, Nunez L, Rossman R, Reid K, Moelling K, Yancopoulos GD and Glass DJ. (1999). Science, 286, 1738-1741.
32. Roymans D and Slegers H. (2001). Eur. J. Biochem., 268, 487-498.
33. Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnofsky S, Lechleider RJ, Neel BG, Birge RB, Fajardo JE, Chou MM, Hanafusa H, Schaffhausen B and Cantley LC. (1993). Cell, 72, 767-778.
34. Stein RC and Waterfield MD. (2000). Mol. Med. Today, 6, 347-357.
35. Sutor SL, Broman BT, Armstrong EA, Abraham RT and Karnitz LM. (1999). J. Biol. Chem., 274, 7002-7010.
36. Toker A and Newton AC. (2000). Cell, 103, 185-188.
37. van Weering D, de Rooij J, Marte B, Downward J, Bos JL and Burgering BM. (1998). Mol. Cell. Biol., 18, 1802-1811.
38. Vassalli J-D and Belin D. (1987). FEBS Lett., 214, 187-191.
39. Wang W, Abbruzzese JL, Evans DB and Chiao PJ. (1999). Oncogene, 18, 4554-4563.
40. Wennstrom S and Downward J. (1999). Mol. Cell. Biol., 19, 4279-4288.
41. Wennstrom S, Landgren E, Blume-Jensen P and Claesson-Welsh L. (1992). J. Biol. Chem., 267, 13749-13756.
42. Wymann MP and Pirola L. (1998). Biochim. Biophys. Acta, 1436, 127-150.
43. Zimmermann S and Moelling K. (1999). Science, 286, 1741-1744.